Production of non-caloric sweeteners using engineered whole-cell catalysts

US10752928B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10752928-B2
Application numberUS-201615566244-A
CountryUS
Kind codeB2
Filing dateApr 14, 2016
Priority dateApr 14, 2015
Publication dateAug 25, 2020
Grant dateAug 25, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are whole-cell catalysts, methods of making the whole-cell catalysts, and methods of using the whole-cell catalysts to produce steviol glycosides.

First claim

Opening claim text (preview).

What is claimed is: 1. A whole-cell catalyst composition for the production of a steviol glycoside, the whole-cell catalyst composition comprising a first whole-cell catalyst, said first whole-cell catalyst being a Pichia pastoris host cell transformed by at least one expression cassette such that the host cell comprises: (a) at least one first nucleotide sequence encoding a HV1-GCW61 fusion protein in which a display polypeptide is fused to the C-terminal of a UDP-glycosyltransferase (UGT) enzyme such that when expressed the UGT enzyme is attached to the surface of the host cell, wherein the first nucleotide sequence comprises a sequence that is at least 80% identical to the sequence set forth in SEQ ID NO: 2; and (b) at least one second nucleotide sequence encoding an intracellular sucrose synthase (SUS). 2. The whole-cell catalyst composition of claim 1 , wherein the SUS comprises at least one of: an SUS derived from Arabidopsis thaliana , an SUS derived from Vigna radiate. 3. The whole-cell catalyst composition of claim 2 , wherein the SUS comprises at least one of: Arabidopsis sucrose synthase 1; Arabidopsis sucrose synthase 3; and Vigna radiate sucrose synthase (mbSUS1). 4. The whole-cell catalyst composition of claim 1 , wherein the Pichia pastoris host cell is transformed to include five copies of the first nucleotide sequence and two copies of the second nucleotide sequence, wherein the second nucleotide sequence comprises the sequence set forth in SEQ ID NO: 12. 5. The whole-cell catalyst composition of claim 1 , wherein the whole-cell catalyst composition comprises a second whole-cell catalyst, said second whole-cell catalyst being a Pichia pastoris host cell transformed to include four copies of a third nucleotide sequence encoding a UGT76G1-GCW61 fusion protein, wherein the third nucleotide sequence comprises the sequence set forth in SEQ ID NO: 4 and two copies of the second nucleotide sequence, wherein the second nucleotide sequence comprises the sequence set forth in-SEQ ID NO: 12. 6. The whole-cell catalyst composition of claim 1 , wherein the first nucleotide sequence comprises the sequence set forth in SEQ ID NO: 2. 7. A method of producing a desired steviol glycoside from a starting steviol glycoside substrate, the method comprising: incubating a whole-cell catalyst composition in a culture medium comprising said starting steviol glycoside substrate, sucrose, UDP and/or UDP-glucose for period such that said starting steviol glycoside substrate is converted to the desired steviol glycoside in the culture medium; wherein the whole-cell catalyst composition comprises a first whole-cell catalyst, said first whole-cell catalyst being a Pichia pastoris host cell transformed by at least one expression cassette such that the host cell comprises: (a) at least one first nucleotide sequence encoding a HV1-GCW61 fusion protein in which a display polypeptide is fused to the C-terminal of a UDP-glycosyltransferase (UGT) enzyme such that when expressed the UGT enzyme is attached to the surface of the host cell, wherein the first nucleotide sequence comprises a sequence that is at least 80% identical to the sequence set forth in SEQ ID NO: 2; and (b) at least one second nucleotide sequence encoding an intracellular sucrose synthase (SUS). 8. The method of claim 7 , wherein the first nucleotide sequence comprises the sequence set forth in SEQ ID NO: 2. 9. The method of claim 7 , wherein the SUS comprises at least one of: an SUS derived from Arabidopsis thaliana , an SUS derived from Vigna radiate. 10. The method of claim 9 , wherein the SUS comprises at least one of: Arabidopsis sucrose synthase 1; Arabidopsis sucrose synthase 3; and Vigna radiate sucrose synthase (mbSUS1). 11. The method of claim 7 , wherein the whole-cell catalyst composition comprises a second whole-cell catalyst, said second whole-cell catalyst being a Pichia pastoris host cell transformed to include four copies of a third nucleotide sequence encoding a UGT76G1-GCW61 fusion protein, wherein the third nucleotide sequence comprises the sequence set forth in SEQ ID NO: 4 and two copies of the second nucleotide sequence, wherein the second nucleotide sequence comprises the sequence set forth in-SEQ ID NO: 12. 12. The method of claim 7 , wherein the Pichia pastoris host cell is transformed to include five copies of the first nucleotide sequence and two copies of the second nucleotide sequence, wherein the second nucleotide sequence comprises the sequence set forth in-SEQ ID NO: 12. 13. The method of claim 11 , wherein the starting steviol glycoside substrate is stevioside and the produced steviol glycoside is rebaudioside A. 14. The method of claim 11 , wherein the starting steviol glycoside substrate is rebaudioside D and the produced steviol glycoside is rebaudioside M. 15. The method of claim 11 , wherein the starting steviol glycoside substrate is rebaudioside E and the produced steviol glycoside is rebaudioside D. 16. The method of claim 12 , wherein the starting steviol glycoside substrate is rebaudioside A and the produced steviol glycoside is rebaudioside D. 17. The method of claim 12 , wherein the starting steviol glycoside substrate is stevioside and the produced steviol glycoside is rebaudioside E. 18. The method of claim 11 , wherein the starting steviol glycoside substrate comprises stevioside, rebaudioside A, or any combination thereof and the produced steviol glycoside is rebaudioside M. 19. The method of claim 12 , wherein the starting steviol glycoside substrate is rebaudioside KA and the produced steviol glycoside is rebaudioside E. 20. The method of claim 12 , wherein the starting steviol glycoside substrate is rubusoside and the produced steviol glycoside is rebaudioside KA. 21. The method of claim 12 , wherein the starting steviol glycoside substrate is rubusoside and the produced steviol glycoside is rebaudioside E. 22. The method of claim 7 , wherein the starting steviol glycoside substrate is selected from the group consisting of rubusoside, rebaudioside KA, stevioside, rebaudioside A, rebaudioside D, rebaudioside E, and any combination thereof. 23. The method of claim 7 for producing a steviol glycoside selected from the group consisting of rebaudioside KA, rebaudioside A, rebaudioside D, rebaudioside E, rebaudioside M, and any combination thereof by glycosylating a starting steviol glycoside substrate selected from the group consisting of rubusoside, rebaudioside KA, stevioside, rebaudioside A, rebaudioside D, rebaudioside E, and any combination thereof. 24. The method of claim 7 , further comprising separating said desired steviol glycoside from the culture medium. 25. The whole-cell catalyst composition of claim 1 , wherein the Pichia pastoris host cell is transformed to include more than one copy of each of said first and second nucleotide sequences.

Assignees

Inventors

Classifications

  • Genes encoding for enzymes or proenzymes · CPC title

  • C12P19/56Primary

    having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin · CPC title

  • C12N9/1048Primary

    Glycosyltransferases (2.4) · CPC title

  • Terpene glycosides · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10752928B2 cover?
Disclosed are whole-cell catalysts, methods of making the whole-cell catalysts, and methods of using the whole-cell catalysts to produce steviol glycosides.
Who is the assignee on this patent?
Conagen Inc
What technology area does this patent fall under?
Primary CPC classification C12P19/56. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).